Immune profiling of circulating T cells and TILs following neoadjuvant ipilimumab and chemotherapy in non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Yi, John
Clarke, Jeffrey Melson
Healy, Patrick
Wang, Xiaofei F.
Shoemaker, Debra
Onaitis, Mark W.
Dumbauld, Chelsae
Osborne, Robyn
Crawford, Jeffrey
Harpole, David
D'Amico, Thomas A.
Dunphy, Frank
Christensen, Jared
Ready, Neal
Weinhold, Kent
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Duke Univ, Dept Biostatist & Bioinformat, Med Ctr, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 07期
关键词：
D O I：
10.1200/JCO.2017.35.7_suppl.26
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
26
引用
收藏
页数：1
相关论文
共 50 条
  • [41] STATUS OF IMMUNE THERAPY IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Parums, D. V.
    [J]. DRUGS OF THE FUTURE, 2014, 39 (07) : 469 - 477
  • [42] EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells
    Stella, Giulia M.
    Scabini, Roberta
    Inghilleri, Simona
    Cemmi, Francesca
    Corso, Simona
    Pozzi, Ernesto
    Morbini, Patrizia
    Valentini, Adele
    Dore, Roberto
    Ferrari, Simona
    Luisetti, Maurizio
    Zorzetto, Michele
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (08) : 1327 - 1335
  • [43] EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells
    Giulia M. Stella
    Roberta Scabini
    Simona Inghilleri
    Francesca Cemmi
    Simona Corso
    Ernesto Pozzi
    Patrizia Morbini
    Adele Valentini
    Roberto Dore
    Simona Ferrari
    Maurizio Luisetti
    Michele Zorzetto
    [J]. Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1327 - 1335
  • [44] Neoadjuvant Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
    Xue, Chongxiang
    Dong, Huijing
    Chen, Ying
    Lu, Xingyu
    Zheng, Shuyue
    Cui, Huijuan
    [J]. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (06): : 779 - 788
  • [45] Genomic profiling and sites of metastasis in non-small cell lung cancer (NSCLC)
    Chan, Kok Hoe
    Lin, Ji
    Sridhar, Arthi
    Jafri, Syed H.
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [46] Neoadjuvant chemotherapy and chemoradiotherapy for locally advanced non small cell lung cancer (NSCLC)
    Gavila, Q
    Almendros, P
    Camps, C
    López-Torrecillas, J
    Safont, M
    Blasco, A
    Garde, J
    Juarez, A
    Iranzo, V
    Sirera, R
    [J]. LUNG CANCER, 2005, 49 : S379 - S380
  • [47] Circulating Tumour Cells in Non-Small Cell Lung Cancer
    O'Byrne, K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S425 - S425
  • [48] Modified spatial architecture of regulatory T cells after neoadjuvant chemotherapy in non-small cell lung cancer patients
    Cai, Siqi
    Zhao, Miaoqing
    Yang, Guanqun
    Li, Chaozhuo
    Hu, Mengyu
    Yang, Liying
    Xing, Ligang
    Sun, Xiaorong
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 137
  • [49] LIFE EXPECTANCY IN PATIENTS WITH STAGE III A NON-SMALL CELL LUNG CANCER (NSCLC) TREATED WITH NEOADJUVANT CHEMORADIOTHERAPY (NCRT), NEOADJUVANT CHEMOTHERAPY (NCT), NEOADJUVANT CHEMOTHERAPY
    Maliarchuk, Katerina
    Ganul, Andrey
    Borisyuk, Bogdan
    Bororov, Leonid
    Shevchenko, Anatoly
    Sovenko, Vladimir
    Kutsenko, Lubov
    [J]. HEALTH PROBLEMS OF CIVILIZATION, 2022, 16 (04) : 302 - 311
  • [50] Suppressive Immune Cell Profiling in Patients with Non-Small Cell Lung Cancer
    Koh, J.
    Lee, K. Y.
    Kim, B.
    Kim, M. S.
    Cho, H. J.
    Bae, Y. H.
    Ku, B. M.
    Sun, J.
    Lee, S.
    Ahn, J. S.
    Park, K.
    Ahn, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S526 - S526
12345